( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1633.1
1408.5
2007.2
1668.1
Total Expenditure
1806.1
1488.9
2011.6
1686
PBIDT (Excl OI)
-173
-80.40
-4.39
-17.90
Other Income
18.3
6.4
38.5
25.8
Operating Profit
-154.7
-73.99
34.10
7.90
Exceptional Items
205.6
NA
22.3
NA
PBDT
-1.40
-108.7
26.90
-36.89
Depreciation
16.4
16.2
15.1
15.8
Profit Before Tax
-17.80
-124.9
11.80
-52.69
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-17.80
-124.9
11.80
-52.69
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-17.80
-124.9
11.80
-52.69
Equity Capital
280.6
231.1
231.1
231.1
Calculated EPS
-0.06
-0.54
0.05
-0.22
Calculated EPS (Annualised)
-0.25
-2.16
0.20
-0.91
No of Public Share Holdings
130790695
107709981
107709981
107709981
% of Public Share Holdings
46.64
46.64
46.64
46.64
PBIDTM% (Excl OI)
-10.59
-5.70
-0.21
-1.07
PBIDTM%
-9.47
-5.25
1.69
0.47
PBDTM%
-0.08
-7.71
1.34
-2.21